MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Cash Flow Overview
Unit: Thousand (K) dollars
Positive Cash Flow Breakdown
Loss on extinguishment of debt
Changes in fair value of freesta...
Proceeds from issuance of prefer...
Others
Negative Cash Flow Breakdown
Net loss
Prepaid expenses and other curre...
Accounts payable
Others
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Cash Flow
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Net loss
-12,802
8,723
-
-
Other comprehensive income (loss)
1
-458
-
-
Net comprehensive loss
-12,801
8,265
-23,186
-9,781
Loss on extinguishment of debt
-3,504
-628
23
0
Changes in fair value of freestanding and hybrid financial instruments designated at fair value option
-1,918
-337
-1,545
-2,310
Provision for inventory obsolescence
-
-
2,000
-
Depreciation and amortization expenses
473
473
477
479
Interest accrued
-
257
-
-
Amortization of debt discount
432
-
-
-
Stock-based compensation, vested and released restricted stock units, and exercised stock options
171
155
116
135
Impairment loss on indefinite-lived intangible assets
-
-
800
-
Amortization of operating lease - right-of-use asset
69
47
66
78
Share in joint venture's loss
-27
-9
-42
-45
Amortization of debt issuance costs, debt discount, and non-cash interest expense
-
-
153
-
Accounts receivable
-60
-1,453
84
264
Other receivable
-24
37
108
-76
Inventory
-503
-780
-29
-91
Prepaid expenses and other current assets
140
-231
-11,529
84
Other assets
11
-37
-1,065
-2
Accounts payable
-138
-3,755
249
1,812
Accrued liabilities
938
41
-53
528
Deferred revenue
-42
-42
-43
-43
Operating lease liability
-68
-49
-62
-73
Total cash provided by (used in) operating activities
-5,338
8,830
-5,488
-4,689
Payment of 2025 note payable
0
4,000
-
-
Payment of convertible notes
0
2,435
0
30
Proceeds from issuance of preferred stock
1,826
-
-
-
Payment of insurance financing
118
180
-
-
Proceeds from issuance of pre-funded warrants
154
-
-
-
Proceeds from convertible notes
0
0
0
0
Purchase of furniture and fixtures
-
-
-13
54
Proceeds from issuance of preferred shares in pipe financing, net of issuance cost
-
-
0
2,377
Total cash used in investing activities
-
-
13
-54
Proceeds from issuance of common shares/gross proceeds from combined offerings-HCWInvestors
-
-
-
1,309
Net proceeds-Placement Agent
-
-
1,309
-
Proceeds from new note-Streeterville Capital Llc
-
-
10,000
-
Net proceeds-Brown Stone Capital Limited
-
-
0
1,000
Proceeds from issuance of shares in at the market offering, net of issuance and offering costs of 0 and 47 in 2026 and 2025, respectively
0
0
-40
3,081
Repayment of insurance financing
0
0
170
169
Payment of tempesta note
0
0
0
0
Total cash provided by (used in) financing activities
1,862
-6,615
9,790
6,259
Effects of foreign exchange rate changes on assets and liabilities
2
17
-10
-196
Net decrease in cash and restricted cash
-3,474
2,232
4,305
1,320
Cash and restricted cash at beginning of the period
10,064
7,832
3,527
8,002
Cash and restricted cash at end of the period
6,590
10,064
7,832
3,527
Cash paid for interest
6
-
-
-
Stock dividends issued as series o preferred stock
9,470
-
-
-
Warrants issued in exchange for preferred stock
4,647
-
-
-
Deemed dividend related to exchange of preferred stock
2,163
-
-
-
First insurance financing
504
-
-
-
Stock issued in exchange of notes payable and accrued interest
113
-
-
-
Recognition of operating lease - right-of-use asset and operating lease liability
109
-
-
-
Deemed contribution related to conversion of preferred stock
8
-
-
-
Common stock issued upon exercise of pre funded warrants
0
-
-
-
Stock issued in exchange of preferred stock
0
-
-
-
Shares issued in exchange of another class of preferred stock
0
-
-
-
Common stock issued to investors in exchange for preferred stock
0
-
-
-
Cash
3,788
-
-
-
Restricted cash
2,802
-
-
-
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Cash Flow
Proceeds from issuance of
preferred stock
$1,826K
Proceeds from issuance of
pre-funded warrants
$154K
Total cash provided by
(used in) financing...
$1,862K
(-75.57%↓ Y/Y)
Effects of foreign
exchange rate changes on...
$2K
(-97.85%↓ Y/Y)
Canceled cashflow
$118K
Net decrease in cash
and restricted cash
-$3,474K
(40.05%↑ Y/Y)
Canceled cashflow
$1,864K
Loss on
extinguishment of debt
-$3,504K
(-92.32%↓ Y/Y)
Changes in fair value of
freestanding and hybrid...
-$1,918K
(20.45%↑ Y/Y)
Accrued liabilities
$938K
(-40.67%↓ Y/Y)
Inventory
-$503K
(-234.49%↓ Y/Y)
Depreciation and
amortization expenses
$473K
(-50.57%↓ Y/Y)
Amortization of debt discount
$432K
Stock-based compensation,
vested and released...
$171K
(-70.52%↓ Y/Y)
Amortization of operating
lease - right-of-use...
$69K
(-52.41%↓ Y/Y)
Accounts receivable
-$60K
(83.05%↑ Y/Y)
Share in joint
venture's loss
-$27K
(64.00%↑ Y/Y)
Other receivable
-$24K
(-284.62%↓ Y/Y)
Payment of insurance
financing
$118K
Total cash provided by
(used in) operating...
-$5,338K
(60.49%↑ Y/Y)
Canceled cashflow
$8,119K
Other comprehensive
income (loss)
$1K
Net comprehensive
loss
-$12,801K
(40.30%↑ Y/Y)
Canceled cashflow
$1K
Prepaid expenses and
other current assets
$140K
(-81.94%↓ Y/Y)
Accounts payable
-$138K
(-110.74%↓ Y/Y)
Operating lease liability
-$68K
(50.36%↑ Y/Y)
Deferred revenue
-$42K
(50.59%↑ Y/Y)
Other assets
$11K
(110.38%↑ Y/Y)
Net loss
-$12,802K
Buy us a coffee
Jaguar Health, Inc. (JAGX)
Jaguar Health, Inc. (JAGX)